SPECTRUM AND SEVERITY OF ADVERSE DRUG REACTIONS DURING TREATMENT OF MULTIDRUG-RESISTANT TUBERCULOSIS PATIENTS. Int. Res. J. Pharm. 2026;17(9):11-17. doi:10.56802/cyzkpf46